1. Home
  2. WEA vs IVVD Comparison

WEA vs IVVD Comparison

Compare WEA & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WEA
  • IVVD
  • Stock Information
  • Founded
  • WEA 2002
  • IVVD 2020
  • Country
  • WEA United States
  • IVVD United States
  • Employees
  • WEA N/A
  • IVVD N/A
  • Industry
  • WEA Trusts Except Educational Religious and Charitable
  • IVVD Biotechnology: Pharmaceutical Preparations
  • Sector
  • WEA Finance
  • IVVD Health Care
  • Exchange
  • WEA Nasdaq
  • IVVD Nasdaq
  • Market Cap
  • WEA 129.0M
  • IVVD 123.8M
  • IPO Year
  • WEA N/A
  • IVVD 2021
  • Fundamental
  • Price
  • WEA $10.73
  • IVVD $0.51
  • Analyst Decision
  • WEA
  • IVVD Strong Buy
  • Analyst Count
  • WEA 0
  • IVVD 3
  • Target Price
  • WEA N/A
  • IVVD $7.52
  • AVG Volume (30 Days)
  • WEA 46.1K
  • IVVD 1.7M
  • Earning Date
  • WEA 01-01-0001
  • IVVD 05-08-2025
  • Dividend Yield
  • WEA 7.87%
  • IVVD N/A
  • EPS Growth
  • WEA N/A
  • IVVD N/A
  • EPS
  • WEA N/A
  • IVVD N/A
  • Revenue
  • WEA N/A
  • IVVD $25,384,000.00
  • Revenue This Year
  • WEA N/A
  • IVVD $606.63
  • Revenue Next Year
  • WEA N/A
  • IVVD $83.30
  • P/E Ratio
  • WEA N/A
  • IVVD N/A
  • Revenue Growth
  • WEA N/A
  • IVVD N/A
  • 52 Week Low
  • WEA $9.60
  • IVVD $0.36
  • 52 Week High
  • WEA $11.29
  • IVVD $2.74
  • Technical
  • Relative Strength Index (RSI)
  • WEA 49.49
  • IVVD 38.07
  • Support Level
  • WEA $10.16
  • IVVD $0.46
  • Resistance Level
  • WEA $10.77
  • IVVD $0.56
  • Average True Range (ATR)
  • WEA 0.26
  • IVVD 0.06
  • MACD
  • WEA -0.00
  • IVVD 0.01
  • Stochastic Oscillator
  • WEA 46.72
  • IVVD 29.24

About WEA Western Asset Bond Fund Share of Beneficial Interest

Western Asset Premier Bond Fund is a diversified closed-end management investment company. Its investment objective is to provide current income and capital appreciation by investing in a diversified portfolio of investment-grade bonds. The Fund invests in sectors, such as financials, energy, telecommunication services, consumer discretionary, healthcare, materials, information technology, and consumer staples.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: